Effect of itraconazole on lytic antibodies levels in chronic Chagas disease
Parasite, 4 3 (1997) 259-262
Published online: 2014-09-23
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Long-term follow-up of individuals with Chagas disease treated with posaconazole and benznidazole in a non-endemic region: the CHAGASAZOL cohort
Joan Roig-Sanchis, Pau Bosch-Nicolau, Aroa Silgado, Fernando Salvador, Adrián Sánchez-Montalvá, Marisa Aznar, Inés Oliveira, Juan Espinosa-Pereiro, Núria Serre-Delcor, Diana Pou, Joan Martínez-Campreciós, Elena Sulleiro and Israel MolinaClinical Microbiology and Infection (2025)
https://doi.org/10.1016/j.cmi.2025.03.018
Trypanocidal treatment of Chagas disease
Jose A. Pérez-Molina, Clara Crespillo-Andújar, Pau Bosch-Nicolau and Israel MolinaEnfermedades Infecciosas y Microbiología Clínica 39 (9) 458 (2021)
https://doi.org/10.1016/j.eimc.2020.04.011
Trypanocidal treatment of Chagas disease
Jose A. Pérez-Molina, Clara Crespillo-Andújar, Pau Bosch-Nicolau and Israel MolinaEnfermedades infecciosas y microbiologia clinica (English ed.) 39 (9) 458 (2021)
https://doi.org/10.1016/j.eimce.2020.04.012
A case report of long treatment with Itraconazole in a patient with chronic Chagas disease
Pau Bosch-Nicolau, Fernando Salvador, Adrián Sánchez-Montalvá, et al.BMC Infectious Diseases 19 (1) (2019)
https://doi.org/10.1186/s12879-019-4608-9